KFF’s analysis found that the average number of issuers offering plans on the Marketplaces declined to 9 issuers per state in 2026, compared to 9.6 issuers per state in 2025. The post KFF: Insurer Participation in ACA Marketplaces Is Down appeared first on MedCity News.
UniQure is preparing to seek accelerated FDA approval for its Huntington’s disease gene therapy, a move that follows the FDA’s reversal of its prior position calling for another clinical trial. This gene therapy is the latest in a growing list of rare disease treatments to receive reconsideration from an FDA that appears to be swinging…
Combined upper and lower GI endoscopy is becoming standard practice across many US healthcare settings, but the quality infrastructure for upper GI has not kept pace with the procedures now being performed on it. The post Combined GI Procedures Are Becoming Routine – AI Can Help Address the Gap in Upper GI Quality Standards appeared…
The healthcare organizations getting this right are not defined by how much they’ve automated. They are defined by how deliberately they’ve protected the human touchpoints that drive trust, engagement, and outcomes. The post The Human Behind the Machine: Why Healthcare Must Resist the Rush To Automate appeared first on MedCity News.
As air transportation for organs becomes more common, both in response to tech advancements and changing federal guidelines, the industry needs tools that synchronize communication between dispersed teams and can keep pace with air transport. The post Leveraging Technology to Navigate the New Era of Continuous Organ Distribution appeared first on MedCity News.
InStride’s Series C round includes support from new investors Echo Health Ventures and FMZ Ventures, as well as existing investors .406 Ventures, Valtruis, General Catalyst and Mass General Brigham Ventures. The post InStride Raises $30M to Scale Pediatric Mental Health Support appeared first on MedCity News.
MultiValent Biotherapies is developing a peptide-like drug conjugate that hits two validated targets to treat prostate cancer. This clinical-stage asset was licensed from China-based Coherent Biopharma. The post New Cancer Biotech Unveils $27M for Dual-Targeting Prostate Cancer Drug appeared first on MedCity News.
Verily is testing wastewater across World Cup host cities for pathogens like RSV, measles and norovirus, aiming to spot outbreaks five to seven days before they show up in clinics. The post What’s Flowing Beneath the World Cup: How Verily’s Wastewater Monitoring Could Catch the Next Outbreak appeared first on MedCity News.
New FDA guidance on the use of Bayesian statistics signals a broader shift in accommodating more flexible clinical trial designs and the complexities of diseases such as certain cancers and rare disorders, which may lead to more efficient trials, lower development costs, and faster innovation. The post The FDA’s Bayesian Guidance Could Quietly Reshape Clinical…
Reframing transportation as infrastructure, not a support service, means holding it to the same standard as any other component of care delivery. That requires these three things. The post Healthcare Access Depends on Infrastructure: Why Rural Communities Can’t Afford Fragmentation appeared first on MedCity News.